Intercept Pharmaceuticals, Inc.

NASDAQ:ICPT

19 (USD) • At close November 7, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202220212020201920182017201620152014201320122011
Assets:
Current Assets:
Cash & Cash Equivalents 50.51784.70958.15170.055436.16414.917689.385628.055239.72413.363110.19417.707
Short Term Investments 435.049334.98411.516582.567392.912344.904645.71595.313219.701131.54764.7590
Cash and Short Term Investments 490.909429.389477.17657.347436.16414.917689.385628.055239.724144.91110.19417.707
Net Receivables 26.86247.61741.54938.04425.69418.57212.3353.6912.5571.3780.5370.637
Inventory 6.4628.619-68.5718.4627.10802.279-3.6443.5471.2770.0360.359
Other Current Assets 21.23726.36734.52522.18713.46314.8183.86613.5910-00.9340.201
Total Current Assets 540.127502.292477.17721.315482.425448.307707.865641.693245.828147.565111.77818.904
Non-Current Assets:
Property, Plant & Equipment, Net 0.9879.49618.65318.44810.41116.18411.29510.0475.8511.6720.1490.311
Goodwill 000000000000
Intangible Assets 000000000000
Goodwill and Intangible Assets 000000000000
Long Term Investments 000000000000
Tax Assets 000000000000
Other Non-Current Assets 12.59715.23584.66615.12316.33119.85620.0934.0182.4691.0820.2520.255
Total Non-Current Assets 13.58424.731103.31933.57126.74236.0431.38814.0658.322.7540.40.566
Total Assets 553.711527.023580.489754.886509.167484.347739.253655.758254.149150.319112.17919.47
Liabilities & Equity:
Current Liabilities:
Account Payables 14.23418.13224.59418.97511.7656.9656.7224.173.1293.1961.180.604
Short Term Debt 109.5693.0427.2486.45682.49100010.334.0642.5660.082
Tax Payables 3.14400000000000
Deferred Revenue 0136.691138.292130.5351.6211.7825.6941.7821.7821.6221.6222.446
Other Current Liabilities 103.138.9528.9426.03918.32895.28766.09641.4210-07.5970.9
Total Current Liabilities 230.077166.817179.076162.005114.205104.03478.51247.37315.2418.88112.9644.032
Non-Current Liabilities:
Long Term Debt 223.104544.168568.266532.078371.25355.677341.35600000
Deferred Revenue Non-Current 00002.4324.45410.1478.0179.7998.91912.16212.162
Deferred Tax Liabilities Non-Current 0000-1.621-1.782000000
Other Non-Current Liabilities 7.453009.2473.7715.578-5.694-1.781-9.79950.11221.1415.836
Total Non-Current Liabilities 230.557544.168568.266541.325375.832363.927345.8096.2368.01759.03133.30317.998
Total Liabilities 460.634710.985747.342703.33490.037467.961424.32153.60923.25867.91246.26722.03
Equity:
Preferred Stock 000000000000.028
Common Stock 0.0420.030.0330.0330.030.0250.0250.0240.0210.0190.0170.003
Retained Earnings -2,136.888-2,489.772-2,398.346-2,123.466-1,778.785-1,469.543-1,108.46-695.63-469.202-185.976-118.183-74.54
Accumulated Other Comprehensive Income/Loss -8.256-2.873-2.477-1.144-2.259-0.786-2.801-2.253-0.2840.06-0.021-0.185
Other Total Stockholders Equity 2,238.1792,308.6532,233.9372,176.1331,800.1441,486.691,426.1681,300.008700.355268.303184.172.134
Total Shareholders Equity 93.077-183.962-166.85351.55619.1316.386314.932602.149230.89182.40665.912-2.56
Total Equity 93.077-183.962-166.85351.55619.1316.386314.932602.149230.89182.40665.912-2.56
Total Liabilities & Shareholders Equity 553.711527.023580.489754.886509.167484.347739.253655.758254.149150.319112.17919.47